Rosiglitazone D3
| Product Name | Rosiglitazone D3 |
|---|---|
| Alternate Names | Rosiglitazone Stable Isotopes, Stable Isotopes of Rosiglitazone |
| CAT No. | CS-O-06941 |
| CAS No. | 1132641-22-5 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 360.45 g/mol |
| Mol. For. | C18H16D3N3O3S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Rosiglitazone |
| Purity | >98% |
| Therapeutic | Anti-Diabetic |
| Smileys | O=C(N1)C(SC1=O)CC2=CC=C(OCCN(C3=CC=CC=N3)C([2H])([2H])[2H])C=C2 |
| Canonical Smiles | CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3 |
| InchIKey | YASAKCUCGLMORW-FIBGUPNXSA-N |
| Inchl | InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)/i1D3 |
| IUPAC | 5-[[4-[2-[pyridin-2-yl(trideuteriomethyl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Rosiglitazone D3 is a potent and selective agonist for peroxisome proliferator-activated receptor gamma (PPARγ). It is used in the treatment of type 2 diabetes mellitus to improve insulin sensitivity and glycemic control. Rosiglitazone D3 works by activating PPARγ, which regulates the expression of genes involved in glucose and lipid metabolism. This leads to increased glucose uptake and utilization in peripheral tissues, decreased hepatic glucose production, and improved insulin sensitivity.
Rosiglitazone D3 is available in tablet form and is typically taken orally once or twice a day. The recommended dosage and duration of treatment may vary depending on the patient's health status and response to therapy. Common side effects of Rosiglitazone D3 include headache, dizziness, fatigue, and edema.
In terms of chemical information, Rosiglitazone D3 is a thiazolidinedione derivative with a molecular formula of C18H18N3O3S2 and a molecular weight of 393.49 g/mol. It is a white to off-white crystalline powder that is soluble in methanol, ethanol, and dimethyl sulfoxide. Rosiglitazone D3 is stable under normal storage conditions and should be kept in a cool, dry place. It is important to note that Rosiglitazone D3 is a prescription medication and should only be used under the supervision of a healthcare provider.
Get an Instant Quote
Related Compounds
Rosiglitazone D4 |